Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05233748 · ClinicalTrials.gov registry record · NA

Neuromotor Control During Walking in Children With Cerebral Palsy

A NA study, sponsored by University of Delaware.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT05233748: Completed NA study, sponsored by University of Delaware.

NCT05233748 is a NA study that has completed, run by University of Delaware. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05233748, a NA study, has completed, sponsored by University of Delaware.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

One out of every three children with cerebral palsy (CP) falls daily, with more than half of the falls occurring while walking. To avoid falling, the nervous system must continuously monitor how the body moves and, when an imbalance is detected, activate muscles for an appropriate correction. In this project, we will use small electrical stimulation of muscles and tendons that enhances the sense of body positioning, to allow children with CP to generate more accurate balance corrections.

Primary Outcome

MOS refers to the distance between extrapolated center of mass (which includes center of mass position and velocity) and the base of support. It has been previously used to measure balance in children with cerebral palsy, patients with stroke, Parkinson Disease, and Multiple Sclerosis. We will measure center of mass using kinetics and kinematic computed through a motion capture system(Qualysis). For the visual perturbation conditions, we will use center of mass excursion as the primary outcome

Interventions

  • DEVICE Stochastic Resonance (SR)

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2020-10-30
Est. Completion 2022-09-28
Phase NA
University of Delaware

106 total trials

What the finished NCT05233748 record still lists

NCT05233748 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Stochastic Resonance (SR) is the first listed.

NCT05233748 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05233748 about?

NCT05233748 is a clinical study titled "Neuromotor Control During Walking in Children With Cerebral Palsy". One out of every three children with cerebral palsy (CP) falls daily, with more than half of the falls occurring while walking. To avoid falling, the nervous system must continuously monitor how the body moves and, when an imbalance is detected, activate muscles for an appropriate correction. In thi...

What is the current status of trial NCT05233748?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2020-10-30. Estimated completion is 2022-09-28.

What interventions are being tested in trial NCT05233748?

The interventions under investigation include: Stochastic Resonance (SR) (DEVICE).

Who is sponsoring clinical trial NCT05233748?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05233748's enrollment target sits among peer trials

34 1570th of 2000 higher than 427 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05233748, the US trial registry maintained by the National Library of Medicine. NCT05233748 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.